Ellen Emken
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ellen Emken has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Anna Pukaluk
Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany
2 shared publications Benedetta Zampa
Helmholtz Pioneer Campus Helmholtz Zentrum München Neuherberg Germany
2 shared publications- Bernardo Miller Naranjo
TUM School of Engineering and Design, Department of Materials Engineering, Technical University of Munich, Garching, Germany
2 shared publications - Doris Roth
Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany
2 shared publications - Feng Ling
University of Southern California Viterbi School of Engineering, 920 Downey Way, Los Angeles, California, 90089-0111, United States
2 shared publications - Janna C. Nawroth
Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Wiley in Advanced Science
- p. e77750
A General High‐Throughput Mucus Microrheology Platform for Quantitative and Scalable Mucus Phenotyping
Mucus mechanics regulate barrier, clearance, and transport functions across epithelial tissues, yet quantitative rheology remains difficult to scale because available assays require large volumes, specialized equipment, or extensive manual analysis. Here, a high‐throughput microrheology workflow based on Differential Dynamic Microscopy is established for frequency‐dependent measurements from 3 to 10 mucus samples and intact mucosal surfaces using standard epifluorescence microscopy. The workflow combines preloaded tracer chambers, controlled sample handling, short video acquisition, and automated analysis to reduce operator intervention while preserving sensitivity to mucus relaxation on 1–20 s time scales. Validation against shear rheometry and particle tracking in reconstituted mucin gels shows robust recovery of viscoelastic trends across mucus‐like material states. Applications in human airway epithelial air–liquid interface cultures resolve culture‐medium, age, donor, COPD, cigarette‐smoke, cystic‐fibrosis treatment, and IL‐13‐associated differences, including spatial heterogeneity in situ. Measurements of clinical cervical mucus further demonstrate parallel testing of scarce specimens and sensitivity to osmotic swelling. This platform provides a scalable route to quantitative mucus phenotyping for disease modeling, therapeutic testing, and future precision‐medicine studies.
- 28 September 2026
- Published by Wiley in Advanced Science
- p. e77750
Open AccessA General High‐Throughput Mucus Microrheology Platform for Quantitative and Scalable Mucus Phenotyping
Mucus mechanics regulate barrier, clearance, and transport functions across epithelial tissues, yet quantitative rheology remains difficult to scale because available assays require large volumes, specialized equipment, or extensive manual analysis. Here, a high‐throughput microrheology workflow based on Differential Dynamic Microscopy is established for frequency‐dependent measurements from 3 to 10 mucus samples and intact mucosal surfaces using standard epifluorescence microscopy. The workflow combines preloaded tracer chambers, controlled sample handling, short video acquisition, and automated analysis to reduce operator intervention while preserving sensitivity to mucus relaxation on 1–20 s time scales. Validation against shear rheometry and particle tracking in reconstituted mucin gels shows robust recovery of viscoelastic trends across mucus‐like material states. Applications in human airway epithelial air–liquid interface cultures resolve culture‐medium, age, donor, COPD, cigarette‐smoke, cystic‐fibrosis treatment, and IL‐13‐associated differences, including spatial heterogeneity in situ. Measurements of clinical cervical mucus further demonstrate parallel testing of scarce specimens and sensitivity to osmotic swelling. This platform provides a scalable route to quantitative mucus phenotyping for disease modeling, therapeutic testing, and future precision‐medicine studies.
- Open Access
- 18 January 2026
- Published by Wiley in Journal of Biophotonics
- Vol. 19 (1) , e70217
Fabry‐Pérot Microscopy for Improved Contrast Enhancement and Quantitative Phase Imaging
Fabry‐Pérot microscopy (FPM) is a label‐free imaging technique that combines a microfluidic optical cavity with a tunable light source to enhance contrast and enable quantitative phase imaging. It integrates a fixed‐length Fabry‐Pérot cavity into a coated microfluidic channel and utilizes resonance‐based interference to selectively highlight structures with specific optical thickness. This design preserves lateral resolution while providing > 20‐fold contrast enhancement compared to conventional wide‐field microscopy. Demonstrations with human oral epithelial cells, blood components, and E. coli show clear visualization of subcellular features and differentiation of cell types. Notably, FPM achieves imaging through spectral tuning rather than mechanical scanning, ensuring faster and more stable operation. The system is compatible with standard microscope optics and works under both static and flow conditions, offering significant potential for high‐throughput cytometry, biological research, and in vitro diagnostics. These results establish FPM as a versatile extension of wide‐field microscopy, enabling contrast‐tunable, quantitative imaging of biomedical samples.
- 18 January 2026
- Published by Wiley in Journal of Biophotonics
- Vol. 19 (1) , e70217
Open AccessFabry‐Pérot Microscopy for Improved Contrast Enhancement and Quantitative Phase Imaging
Fabry‐Pérot microscopy (FPM) is a label‐free imaging technique that combines a microfluidic optical cavity with a tunable light source to enhance contrast and enable quantitative phase imaging. It integrates a fixed‐length Fabry‐Pérot cavity into a coated microfluidic channel and utilizes resonance‐based interference to selectively highlight structures with specific optical thickness. This design preserves lateral resolution while providing > 20‐fold contrast enhancement compared to conventional wide‐field microscopy. Demonstrations with human oral epithelial cells, blood components, and E. coli show clear visualization of subcellular features and differentiation of cell types. Notably, FPM achieves imaging through spectral tuning rather than mechanical scanning, ensuring faster and more stable operation. The system is compatible with standard microscope optics and works under both static and flow conditions, offering significant potential for high‐throughput cytometry, biological research, and in vitro diagnostics. These results establish FPM as a versatile extension of wide‐field microscopy, enabling contrast‐tunable, quantitative imaging of biomedical samples.
- Open Access
A General High-throughput Mucus Microrheology Platform For Personalized Medicine
One-Sentence Summary: We here develop and validate an easy to implement, high-throughput microrheology platform to reliably quantify viscoelasticity in as little as 3 µL mucus droplet samples or intact mucosal surfaces based on Differential Dynamic Microscopy (DDM) that we demonstrate in a variety of in vitro and clinical applications. Mucus plays an integral role in the barrier function of many epithelial tissues, including respiratory, gastrointestinal, and reproductive systems. Understanding how mucus flow behavior, i.e., rheology, changes during disease progression and in response to treatments is of great interest for better differential diagnostics, pinpointing patient-specific disease mechanisms and respective personalized treatments. However, both basic and translational research of mucus rheology is greatly hampered by the lack of scalable and user-friendly rheology assays for the small volumes of mucus typically provided by in vitro respiratory models or from clinical samples. We report a streamlined, high-throughput, semi-automated mucus rheology approach, easy to implement for a variety of preclinical and clinical questions. It leverages Differential Dynamic Microscopy (DDM) to reliably measure the frequency-dependent microrheology of minuscule (3–10 µL-sized) mucus samples as well as in situ mucosal surfaces using standard epifluorescence microscopy. Overcoming complex and time-consuming user interventions of previous rheology and particle tracking routines, we achieve microrheology at the time scale of mucus relaxation (1–20 s), greatly reducing assay time. We validated our platform successfully in mucus samples and in situ mucosal surfaces: first in state-of-the-art air-liquid-interface (ALI) human respiratory cultures, where we compare mucus rheology of airway disease models and different culture conditions; second, assessing clinical samples of human patient cervical samples. Overall, our results add to an increasingly appreciated non-invasive, easy to use, body fluid-based personalized toolbox, with unprecedented opportunities for precision medicine and large-scale monitoring to further unveil functional roles of mucus in human health and disease.
Open AccessA General High-throughput Mucus Microrheology Platform For Personalized Medicine
One-Sentence Summary: We here develop and validate an easy to implement, high-throughput microrheology platform to reliably quantify viscoelasticity in as little as 3 µL mucus droplet samples or intact mucosal surfaces based on Differential Dynamic Microscopy (DDM) that we demonstrate in a variety of in vitro and clinical applications. Mucus plays an integral role in the barrier function of many epithelial tissues, including respiratory, gastrointestinal, and reproductive systems. Understanding how mucus flow behavior, i.e., rheology, changes during disease progression and in response to treatments is of great interest for better differential diagnostics, pinpointing patient-specific disease mechanisms and respective personalized treatments. However, both basic and translational research of mucus rheology is greatly hampered by the lack of scalable and user-friendly rheology assays for the small volumes of mucus typically provided by in vitro respiratory models or from clinical samples. We report a streamlined, high-throughput, semi-automated mucus rheology approach, easy to implement for a variety of preclinical and clinical questions. It leverages Differential Dynamic Microscopy (DDM) to reliably measure the frequency-dependent microrheology of minuscule (3–10 µL-sized) mucus samples as well as in situ mucosal surfaces using standard epifluorescence microscopy. Overcoming complex and time-consuming user interventions of previous rheology and particle tracking routines, we achieve microrheology at the time scale of mucus relaxation (1–20 s), greatly reducing assay time. We validated our platform successfully in mucus samples and in situ mucosal surfaces: first in state-of-the-art air-liquid-interface (ALI) human respiratory cultures, where we compare mucus rheology of airway disease models and different culture conditions; second, assessing clinical samples of human patient cervical samples. Overall, our results add to an increasingly appreciated non-invasive, easy to use, body fluid-based personalized toolbox, with unprecedented opportunities for precision medicine and large-scale monitoring to further unveil functional roles of mucus in human health and disease.